J.L. Boormans
Papers
1
Total Citations
7
H-Index
1
About
Dr. J.L. Boormans is a leading urologic oncologist whose research centers on the surgical management of upper tract urothelial carcinoma (UTUC) and other genitourinary malignancies. His major contributions include landmark comparative effectiveness studies evaluating open, laparoscopic, and robotic surgical approaches for UTUC. In a pivotal 2023 multicenter, multinational propensity score-matched analysis, Dr. Boormans and colleagues demonstrated that robotic radical nephroureterectomy offers comparable oncologic outcomes to open and laparoscopic approaches, with potential perioperative advantages. This work, already garnering 7 citations, has helped guide surgical decision-making for this rare but aggressive cancer. Beyond UTUC, Dr. Boormans has contributed extensively to bladder cancer research, investigating neoadjuvant chemotherapy response, novel biomarkers, and quality-of-life outcomes. His collaborative, data-driven approach has positioned him as a key figure in evidence-based urologic oncology, with his publications shaping clinical guidelines and improving patient care through rigorous comparative effectiveness research.
Research Focus
Key Achievements
Top Papers
- 1